BiotechTube

Sevoflurane + propofol + remifentanil

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Intra-abdominal and Intrapelvic Surgery

Conditions

Intra-abdominal and Intrapelvic Surgery

Trial Timeline

Mar 1, 2013 → Apr 1, 2019

NCT ID
NCT01809041

About Sevoflurane + propofol + remifentanil

Sevoflurane + propofol + remifentanil is a approved stage product being developed by Baxter for Intra-abdominal and Intrapelvic Surgery. The current trial status is completed. This product is registered under clinical trial identifier NCT01809041. Target conditions include Intra-abdominal and Intrapelvic Surgery.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01809041ApprovedCompleted

Competing Products

20 competing products in Intra-abdominal and Intrapelvic Surgery

See all competitors
ProductCompanyStageHype Score
Relebactam 250 mg + Relebactam 125 mg + Imipenem/cilastatin + Matching placebo to relebactamMerckPhase 2
52
Ceftolozane/Tazobactam + Metronidazole + Meropenem + PlaceboMerckPhase 3
77
MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g) + metronidazole 500 mgMerckPhase 3
77
CXA-201 and metronidazole + MeropenemMerckPhase 3
77
Imipenem+Cilastatin/RelebactamMerckPhase 3
77
CXA-101/ tazobactam and metronidazole + meropenem plus saline placeboMerckPhase 2
52
Ceftolozane/Tazobactam + Metronidazole + Meropenem + Placebo for MetronidazoleMerckPhase 2
52
Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks + MK0826, /Duration of Treatment : 8 Weeks + Comparator: metronidazole / Duration of Treatment: 8 WeeksMerckPhase 3
77
MK0826; ertapenem sodium + Comparator: ceftriaxone + metronidazoleMerckApproved
85
MK0826, /Duration of Treatment : 8 Weeks + Comparator : piperacillin sodium (+) tazobactam sodium /Duration of Treatment : 8 WeeksMerckPhase 3
77
LYS228 + Standard of care therapyNovartisPhase 2
52
Ceftazidime-avibactam + metronidazole + MeropenemPfizerPhase 3
76
Tigecycline + Imipenem/cilastatinPfizerApproved
84
ceftazidime/NXL104 + metronidazole + meropenemPfizerPhase 2
51
ATM-AVI + MetronidazolePfizerPhase 2
51
Tigecycline (Tygacil)PfizerPre-clinical
22
Ceftazidime -avibactam + Meropenem + MetronidazolePfizerPhase 2
51
PF-06947386 + MetronidazolePfizerPhase 3
76
TigecyclinePfizerPre-clinical
22
CAZ-AVI + Metronidazole + MeropenemPfizerPhase 3
76

Other Products from Baxter

FLOSEAL Hemostatic Matrix + Standard of careApproved
82
Esmolol + MetoprololApproved
82
Fibrin Sealant (Tisseel) used in the Experimental Arm.Approved
82
Physioneal + Dianeal + Extraneal + NutrinealApproved
82
Extraneal (7.5% icodextrin) Peritoneal Dialysis SolutionApproved
82